부산대학교 도서관

Munster P; Mita M; Mahipal A; Nemunaitis J; Massard C; Mikkelsen T; Cruz C; Paz-Ares L; Hidalgo M; Rathkopf D; Blumenschein Jr G; Smith DC; Eichhorst B; Cloughesy T; Filvaroff EH; Li S; Raymon H; de Haan H; Hege K; Bendell JC

Cancer Management and Research, Vol Volume 11, Pp 10463-10476 (2019)

Arrillaga-Romany I; Mass General Cancer Center, Neuro-Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA.; Lassman A; Columbia University Vagelos College of Physicians and Surgeons, Herbert Irving Comprehensive Cancer Center, New York-Presbyterian Hospital, New York City, New York, USA.; McGovern SL; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Mueller S; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA.; Nabors B; Department of Neuro-Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA.; van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Vogelbaum MA; Moffitt Cancer Center, Tampa, Florida, USA.; Allen JE; Chimerix, Inc., Durham, North Carolina, USA.; Melemed AS; Chimerix, Inc., Durham, North Carolina, USA.; Tarapore RS; Chimerix, Inc., Durham, North Carolina, USA.; Wen PY; Center For Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Cloughesy T; Bowyer Oncology Center, University of California Los Angeles, Los Angeles, California, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Arrillaga-Romany I; Massachusetts General Hospital, Boston, MA.; Gardner SL; New York University, Grossman School of Medicine, New York, NY.; Odia Y; Miami Cancer Institute, part of Baptist Health South Florida, Miami, FL.; Aguilera D; Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA.; Allen JE; Chimerix, Inc, Durham, NC.; Batchelor T; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.; Butowski N; University of California, San Francisco, CA.; Chen C; University of Minnesota Medical Center, Minneapolis, MN.; Cloughesy T; University of California, Los Angeles, CA.; Cluster A; Washington University of St Louis, St Louis, MO.; de Groot J; University of California, San Francisco, CA.; Dixit KS; Northwestern Medical Lou and Jean Malnati Brain Tumor Institute, Chicago, IL.; Graber JJ; University of Washington Medical Center, Seattle, WA.; Haggiagi AM; Columbia University Irving Medical Center, New York, NY.; Harrison RA; BC Cancer, The University of British Columbia, Vancouver, BC, Canada.; Kheradpour A; Loma Linda University, Loma Linda, CA.; Kilburn LB; Children's National Hospital, Washington, DC.; Kurz SC; University Hospital Tuebingen, Tuebingen, Germany.; Lu G; Oncoceutics Inc, Philadelphia, PA.; MacDonald TJ; Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA.; Mehta M; Miami Cancer Institute, part of Baptist Health South Florida, Miami, FL.; Melemed AS; Chimerix, Inc, Durham, NC.; Nghiemphu PL; University of California, Los Angeles, CA.; Ramage SC; Chimerix, Inc, Durham, NC.; Shonka N; University of Nebraska Medical Center, Omaha, NE.; Sumrall A; Levine Cancer Institute, Charlotte, NC.; Tarapore RS; Chimerix, Inc, Durham, NC.; Taylor L; University of Washington Medical Center, Seattle, WA.; Umemura Y; University of Michigan, Ann Arbor, MI.; Wen PY; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Friedman HS; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Prados MD; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Wen PY; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Mikkelsen T; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Schiff D; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Abrey LE; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Yung WKA; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Paleologos N; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Nicholas MK; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Jensen R; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Vredenburgh J; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Huang J; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Zheng M; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.; Cloughesy T; From the Brain Tumor Center, Duke University, Durham, NC; Department of Neurosurgery, University of California, San Francisco, San Francisco; Genetech Inc, South San Francisco; and Department of Neurology, University of California, Los Angeles School of Medicine, Los Angeles, CA; Department of Neurology, Brigham and Women's Hospital and Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA; Hermelin Brain Tumor Center, Henry Ford Hospital, Detroit, MI; Department of Neurology, University of Virginia, Charlottesville, VA; Department of Neurology, Memorial Sloan-Kettering Cancer Center, New York, NY; Department of Neuro-Oncology, M. D. Anderson Cancer Center, Houston, TX; Division of Neurology, Evanston Northwestern Healthcare, Evanston, IL; Department of Neurology, University of Chicago, Chicago, IL; and University of Utah Hospital, Salt Lake City, UT.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: PubMed not MEDLINE; MEDLINE

Wirsching HG; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland. hans-georg.wirsching@usz.ch.; Felsberg J; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Düsseldorf, Germany.; Prummer M; NEXUS Personalized Health Technologies and Swiss Institute of Bioinformatics, ETH Zurich, Zurich, Switzerland.; Moisoiu V; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.; Lourman R; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.; Hertler C; Department of Radiation Oncology, Competence Center for Palliative Care, University Hospital and University of Zurich, Zurich, Switzerland.; Antonios M; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.; Cimino PJ; Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.; Roth P; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.; Gorlia T; European Organization for Research and Treatment of Cancer, Brussels, Belgium.; Prins RM; Department of Neurosurgery, University of California Los Angeles (UCLA), Los Angeles, CA, USA.; Cloughesy T; Department of Neurosurgery, University of California Los Angeles (UCLA), Los Angeles, CA, USA.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Holland EC; Human Biology Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Reifenberger G; Institute of Neuropathology, Medical Faculty, Heinrich Heine University and University Hospital Düsseldorf, Düsseldorf, Germany.; Partner Site Essen/Düsseldorf, German Cancer Consortium (DKTK), Düsseldorf, Germany.; Weller M; Department of Neurology, University Hospital and University of Zurich, Frauenklinikstrasse 26, CH-8091, Zurich, Switzerland.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

Rahman R; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.; Ventz S; Division of Biostatistics, University of Minnesota, Minnesota, Minnesota.; Redd R; MS Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cloughesy T; Neuro-Oncology Program and Department of Neurology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.; Alexander BM; Department of Radiation Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts.; Foundation Medicine, Inc., Cambridge, Massachusetts.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Trippa L; Department of Data Sciences, Dana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Omuro A; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Brandes AA; AUSL-IRCCS Institute of Neurological Sciences, Bologna, Italy.; Carpentier AF; Université de Paris, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Louis, Service de Neurologie, Paris, France.; Idbaih A; Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, AP-HP, Hôpital Universitaire La Pitié Salpêtrière, DMU Neurosciences, Paris, France.; Reardon DA; Dana-Farber Cancer Center, Harvard Medical School, Boston, Massachusetts, USA.; Cloughesy T; Department of Neurology, University of California, Los Angeles, California, USA.; Sumrall A; Levine Cancer Institute, Charlotte, North Carolina, USA.; Baehring J; Department of Neurology, Yale School of Medicine, New Haven, Connecticut, USA.; van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Bähr O; Dr. Senckenberg Institute of Neurooncology, Goethe University Hospital, Frankfurt, Germany.; Lombardi G; Department of Oncology, Oncology 1, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Mulholland P; University College London Hospitals, London, UK.; Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tuebingen, Eberhard Karls University, Tuebingen, Germany.; Lassen U; Department of Oncology, Rigshospitalet, Copenhagen, Denmark.; Sepulveda JM; Hospital Universitario 12 de Octubre, Madrid, Spain.; Khasraw M; The University of Sydney, Sydney, New South Wales, Australia.; Vauleon E; Centre Eugene Marquis, Rennes, France.; Muragaki Y; Tokyo Women's Medical University Hospital, Tokyo, Japan.; Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy.; Butowski N; Department of Neurological Surgery, University of California, San Francisco, California, USA.; Roth P; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; Qian X; Bristol Myers Squibb, Princeton, New Jersey, USA.; Fu AZ; Bristol Myers Squibb, Princeton, New Jersey, USA.; Liu Y; Bristol Myers Squibb, Princeton, New Jersey, USA.; Potter V; Bristol Myers Squibb, Princeton, New Jersey, USA.; Chalamandaris AG; Bristol Myers Squibb, Braine-L'Alleud, Belgium.; Tatsuoka K; Bristol Myers Squibb, Princeton, New Jersey, USA.; Lim M; The Johns Hopkins Hospital, Baltimore, Maryland, USA.; Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Miller JJ; Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Gonzalez Castro LN; Harvard Medical School, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.; McBrayer S; Children's Medical Center Research Institute, University of Texas Southwestern Medical Center, 6000 Harry Hines Blvd, Dallas, Texas, 75235, USA.; Weller M; Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland.; Cloughesy T; UCLA Neuro-Oncology Program, Los Angeles, CA, USA.; Portnow J; Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.; Andronesi O; Harvard Medical School, Boston, MA, USA.; Department of Radiology, Massachusetts General Hospital, Boston, MA, USA.; Barnholtz-Sloan JS; Informatics and Data Science (IDS), Center for Biomedical Informatics and Information Technology (CBIIT), Trans-Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, MD, USA.; Baumert BG; Cantonal Hospital Graubunden, Institute of Radiation-Oncology, Chur, Switzerland.; Berger MS; Department of Neurosurgery, University of California-San Francisco, San Francisco, California, USA.; Bi WL; Harvard Medical School, Boston, MA, USA.; Department of Neurosurgery, Brigham and Women's Hospital, Boston, MA, USA.; Bindra R; Department of Therapeutic Radiology, Brain Tumor Center, Yale School of Medicine, New Haven, CT, USA.; Cahill DP; Department of Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.; Chang SM; Department of Neurosurgery, University of California-San Francisco, San Francisco, California, USA.; Costello JF; Department of Neurosurgery, University of California-San Francisco, San Francisco, California, USA.; Horbinski C; Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Department of Neurological Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Northwestern Medicine Malnati Brain Tumor Institute of the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.; Huang RY; Harvard Medical School, Boston, MA, USA.; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Jenkins RB; Individualized Medicine Research, Mayo Clinic, Department of Laboratory Medicine and Pathology, Rochester, Minnesota 55901, USA.; Ligon KL; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Mellinghoff IK; Department of Neurology, Evnin Family Chair in Neuro-Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Nabors LB; Department of Neurology, Heersink School of Medicine, The University of Alabama at Birmingham, Birmingham, Alabama, USA.; Platten M; CCU Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Reardon DA; Harvard Medical School, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.; Shi DD; Harvard Medical School, Boston, MA, USA.; Department of Radiation Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Schiff D; Division of Neuro-Oncology, Department of Neurology, University of Virginia Health System, Charlottesville, Virginia, USA.; Wick W; Neuro-Oncology at the German Cancer Research Center (DKFZ), Program Chair of Neuro-Oncology at the National Center for Tumor Diseases (NCT), and Neurology and Chairman at the Neurology Clinic in Heidelberg, Heidelberg, Germany.; Yan H; Genetron Health Inc, Gaithersburg, Maryland 20879, USA.; von Deimling A; Department of Neuropathology, University Hospital Heidelberg, and, Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), and, DKTK, INF 224, 69120 Heidelberg, Germany.; van den Bent M; Brain Tumour Centre, Erasmus MC Cancer Institute, Groene Hilledijk 301, 3075 EA Rotterdam, The Netherlands.; Kaelin WG; Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Wen PY; Harvard Medical School, Boston, MA, USA.; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Sloan AE; Chief of Neuroscience, Piedmont Healthcare, Atlanta, USA. Andrew.Sloan@Piedmont.org.; Nock CJ; Department of Medicine, UH-Seidman Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH, USA.; Ye X; Adult Brain Tumor Consortium, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Buerki R; Department of Neurology, UH-Seidman Cancer Center and Case Comprehensive Cancer Center, Cleveland, OH, USA.; Chang S; Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA.; Lesser G; Department of Radiation Oncology, Wake Forest University, Wake Forest, NC, USA.; Norden A; Department of Medicine, Dana Farber Cancer Institute, Boston, MA, USA.; Cloughesy T; Department of Neurology, University of California, Los Angeles, Los Angeles, CA, USA.; Olson J; Department of Neurosurgery, Emory University, Atlanta, GA, USA.; Kerstetter-Fogle A; Chief of Neuroscience, Piedmont Healthcare, Atlanta, USA.; Rich J; Department of Neurology and Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.; Fisher J; Adult Brain Tumor Consortium, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Desideri S; Adult Brain Tumor Consortium, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Takebe N; National Cancer Institute, Clinical Investigations Branch, National Institutes of Health, Bethesda, MD, USA.; Timmer W; National Cancer Institute, Clinical Investigations Branch, National Institutes of Health, Bethesda, MD, USA.; Grossman S; Adult Brain Tumor Consortium, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Prados M; Department of Neurosurgery, University of California, San Francisco, San Francisco, CA, USA.

Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE

Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Standifer N; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, South San Francisco, California.; Dietrich J; Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts.; Clarke JL; Departments of Neurology and Neurosurgery, University of California, San Francisco, San Francisco, California.; Dunn GP; Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri.; Lim M; Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Cloughesy T; Department of Neurology, University of California, Los Angeles, Los Angeles, California.; Gan HK; Department of Medical Oncology, Austin Health, Melbourne, Australia.; Flagg E; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.; George E; Department of Radiology and Biomedical Imaging, University of California, San Francisco, San Francisco, California.; Gaffey S; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hayden J; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Holcroft C; PROMETRIKA, LLC, New York, New York.; Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Macri M; Ludwig Cancer Research, New York, New York.; Park AJ; Ludwig Cancer Research, New York, New York.; Ricciardi T; Ludwig Cancer Research, New York, New York.; Ryan A; Ludwig Cancer Research, New York, New York.; Schwarzenberger P; Ludwig Cancer Research, New York, New York.; Venhaus R; Ludwig Cancer Research, New York, New York.; Reyes ML; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland.; Durham NM; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland.; Creasy T; Translational Medicine Oncology, Early and Early Oncology, R&D, Gaithersburg, Maryland.; Huang RY; Department of Radiology, Brigham and Women's Hospital, Boston, Massachusetts.; Kaley T; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE